Access

Neglected diseases: MSF's exhibition takes to the road

31

27

USA: problems of access to drugs

31

27

A formula to calculate budgetary allocations to health districts in a South African Province. C. Ferdi Blok, M. Zweygarth, R. Summers

31

32

Conference calls for action on neglected diseases

31

33

WHO fact sheet on drug price information services

31

34

The Medicines Crossing Borders Project - improving the quality of donations. WEMOS

31

35

Germany's new drug donation declaration

31

35

Conference explores intellectual property issues post-Doha

31

36

Essential drugs: experts debate differential pricing and financing

30

11

Drug procurement - the principles for getting it right

30

13

WHO and partners - taking the initiative to make a healthier world

28/29

22

New drugs needed to fight TB

28/29

23

Beating malaria: leaders pledge action at historic summit

28/29

23

NGO meetings on drug access

28/29

24

Trade and access:Ugandan groups push for progress

28/29

24

Transforming drug supply in Dar es Salaam. K. Wiedenmayer, D. Mtasiwa

28/29

25

Why do the poor pay more? Survey reveals disparity in drug prices

28/29

27

Antimicrobial resistance

Antimicrobial resistance: the facts

28/29

7

Who contributes to misuse of anti-microbials? K. Holloway

28/29

9

Problems from antimicrobial use in farming. K. Stohr

28/29

10

Promoting resistance? J. Lexchin

28/29

11

Antibiotic use and bacterial resistance to antibiotics in children in a Vietnamese community

28/29

12

Working to decrease costs of anti-TB drugs. M. Espinal, R. Gupta, M. Raviglione

28/29

12

How Chile tackled overuse of anti-microbials. L. Bavestrello, A. Cabello

28/29

13

Nepal: an economic strategy to improve prescribing

28/29

14

Containing drug resistance through hospital infection control. N. Damani

28/29

15

Changing prescriber behaviour in Uganda

28/29

15

Prioritising interventions to contain antimicrobial resistance. K. Holloway

28/29

16

Useful websites on antimicrobial resistance

28/29

18

Pioneers of antimicrobial resistance

28/29

19

Conflict of interest

Editors act on clinical trial reporting

31

2

More journal editors voice their concerns

31

2

Maintaining the integrity of the clinical evidence base. J.D. Quick.

31

3

USA: growing reaction to drug representatives' visits?

31

3

Study shows links between industry and clinical guide writers

31

4

Guidelines on financial conflicts of interest

31

4

Drug donations

Strategies to strengthen effectiveness of drug donations

27

27

Two videos promote good donation practice

27

27

Promoting good donation practice in Kosovo

27

27

Drugs in disasters: encouraging the good, paying for the bad

27

28

Drug information

Medical products and the Internet: WHO's guide to safe surfing

30

18

Breakthrough on developing countries' access to journals

30

20

Pakistan's first Drug Helpline for pro- 28/29 fessionals and patients. A. Ahmed

28

UK's new bulletin fills patient 28/29 information gap

29

Transparency in US drug approval 28/29 system - a lesson for others?

29

Going from strength to strength - 28/29 Iran's Drug and Poison Information Service. S. Nikfar, M. Abdollahi, A. Cheraghali

30

Patient information leaflets promote prescriber competence. J. Collier

27

9

More on patient information...UK survey shows NSAIDS patient leaflets unclear. A. Herxheimer

27

9

Clearly better? US consumers benefit from new non prescription drug labels

27

10

Seminar promotes independent drug bulletins in CEE and NIS

27

10

Getting the message across: communi- 25/26 cations and pharmacovigilance. B. Hugman

26

Improving drug information in Moldova 25/26

26

WHO information on the move: 25/26 introducing the blue trunk library

27

United and committed: Asia-Pacific's 25/26 drug bulletin editors meet

27

Drug information network in Nepal: bringing professionals together

22

15

Drug exports to developing countries: problems remain unsolved. B. van der Heide

20

6

Philippines' Drug Information Centre making a real contribution

20

4

New drug information service at a teaching hospital in Nepal. M.P. Joshi

20

4

Drug promotion

Women and drug promotion: "the essence of womanhood is now in tablet form". B. Mintzes

31

12

Europe: call to leave current advertising regulations intact

31

14

New report on French sales representatives' visits

31

15

FDA reviews its direct-to-consumer advertising policy

31

15

An innovative approach to educating medical students about pharmaceutical promotion M. Wilkes, J. Hoffman

31

16

New WHO/NGO database on drug promotion launched

31

18

Direct-to-consumer prescription drug advertising: is there evidence of health benefits? B. Mintzes

31

19

The Australian Pharmaceutical Manufacturers Association Code of Conduct: guiding the promotion of prescription medicines L. Roughead

31

20

India: campaign to tackle unethical pro- motion. S. Gopalakrishnan, R. Murali

31

22

Doctors and drug companies: analysing a complex relationship

31

22

Tanzania moves to control drug promotion

20

16

US fraud alert targets unethical promotion

20

16

Drug regulation

Improving drug use

32

2

Global harmonization and the International Conference on Harmonization of Technical Requirements for Human Use

30

9

International Society of Drug Bulletins assesses the transparency of drug regulatory agencies. D. Bardelay

24

21

Financing

Drug pricing survey in KwaZulu-Natal.

32

4

A. Kishuna

Drug pricing survey - preliminary findings

32

5

in Sri Lanka, Armenia and Kazakhstan

National drug policy (NDP)

Access to essential drugs a global necessity. Speech by WHO Director-General, Dr Gro Harlem Brundtland at the 25th anniversary celebration of the essential drugs concept

32

12

Memories of the First Expert Committee on the Selection of Essential Drugs. M. Helling-Borda

32

14

Twenty-five years of essential medicines: events around the world

32

15

Personal reflections on 25 years of the WHO Model List of Essential Medicines. R. Laing

32

16

WHO'S new Model Formulary - promoting consumer rights and patient safety

32

24

How to develop national drug policies. New WHO guidelines

31

23

Brazil boosts information on generics

31

25

How to implement national drug policies successfully. S. Phanouvong, S. Barraclough, K. Harvey

31

26

Meetings give impetus to Africa's essential drugs programmes

28/29

20

Brazil: WHO's Director-General speaks out for generics

28/29

20

Launch of the Australian National Medicines Policy. A. Smith

28/29

21

Progress on drug policy in the Former Yugoslav Republic of Macedonia

28/29

21

Promoting essential drugs, rational drug use and generics - Brazil's National Drug Policy leads the way. J. Yunes

27

22

Jordan on course for National Drug Policy implementation. M. Everard

27

23

Belarus: progress in the pharmaceutical sector

25/26

13

Zimbabwe launches NDP

25/26

14

Involving African consumers in drug policy

25/26

14

DAP support - making a difference in Guinea. K. Timmermans

22

7

Pharmaceutical project in Chad

22

8

Comparing NDPs: important new data

22

8

Iran: an evolving NDP. R. Dinarvand

22

9

Oman develops NDP

22

10

Eritrea: national workshop revises essential drugs list

22

10

Ensuring value for money from pharmaceuticals in CCEE/NIS. F. Stobbelaar

22

11

South Africa's new NDP. Interview with Health Minister, N.K. Zuma

21

17

Meeting health needs through NDPs. International Conference, Sydney, 1995

21

20

Developing NDPs: WHO update

21

22

Asia-Pacific seminar promotes NDPs

21

22

Networks

MaLAM: networking for scientific integrity in drug promotion. P. Mansfield, J. Lexchin

24

5

INDEPTH: rational pharmacotherapy

24

6

The International Network for Rational Use of Drugs. D. Lee

24

7

The Pakistan Network. Z. Mirza

24

8

Health Action International: networking for rational drug use. B. van der Heide, C. Hodgkin

24

9

Europharm Forum: involving pharmacists in improving patient care

24

10

ISDB: dedicated to ensuring reliable drug information. E. 't Hoen

24

11

French journal's readers form a network. D. Bardelay

24

12

E-DRUG: the Internetwork

24

13

The BUKO pharmaceuticals campaign

24

13

SIGN - pointing to the future for clinical guidelines. J. Petrie, J. Harlen

24

14

The Cochrane Collaboration

24

15

INCLEN: responding to the challenges of health care into the 21st century

24

16

The AIS Network in Bolivia. O. Lanza, R. Urquieta

24

17

ERDU: Educators for rational drug use. K. Balasubramaniam

24

18

Africa's network of drug regulatory authorities

24

19

From newsletter to network? P. Spivey, M. Everard

24

19

APUA: an international network to combat antibiotic resistance

24

20

Newsdesk

Preventing malaria in Malawi. D. Chevasse, C. Kolwicz, B. Smith

30

2

Historic Ministerial Declaration on public health and TRIPS in Doha

30

4

Useful web sites and electronic discussion groups on pharmaceutical issues

30

8

Reaching out to NGOs and industry

27

12

Trade in pharmaceuticals: is legislation effective?

23

17

WHO calls for action on spread of drug- resistant diseases

20

13

African study provides more evidence of antibiotic misuse

20

13

Public education

CBIA: improving the quality of selfmedication through mothers' active learning. S. Suryawati

32

22

Health and the media: getting the message across. S. Long, S. Gnanakan, D. David

24

4

Eritrea: a community ORT education programme underway. B. Snell

21

3

Consumers and drugs in Poland. B. Mintzes

21

2

Rational use

Dispensing prescribers - a threat to appropriate medicine use? B. Trap, E. Holme Hansen Drug and therapeutics committees: vehicles for improving rational drug

32

9

use. T. Green, A. Beith, J. Chalker

32

10

Drug utilization in Latin America - the exampleof DURG-LA. H. Buschiazzo, A. Chaves, A. Figueras, J-R Laporte

32

17

Indian hospital drug use study shows need to improve prescribing. G. Simpson, D. Govinda Das

32

23

Developing clinical practice guidelines? Australia updates methodology

31

28

Germany: action on overprescribing

31

29

China's first problem-based pharmaco-therapy teaching workshop

31

29

US study shows cost-cutting potential of generics

31

29

Swiss Quality Circles: improving health care, reducing costs

30

22

Street theatre reinforces rational use message in Delhi. M. Lal

30

23

Humanitarian agency's essential drugs policy

30

23

Modernising patient treatment in Nepal

30

23

Oman creates Directorate of Rational Drug Use. B. Jaffe Suleiman, B. Gunn

30

28

Rational use of drugs: Delhi's change in policy saves lives. R. Roy Chaudhury

27

2

Developing lifetime pharmacology skills in India. B. Gitanjali

27

4

Problem-based pharmacotherapy in practice in Argentina

27

5

Crack down on illegal sale of medicines in Benin

27

5

South Africa: getting essential medicines to the people

27

6

Congress promotes rational use of medicines in Argentina

27

7

People and medicines in East Africa. P. Wenzel Geissler

27

8

Celebrating 50 years of pharmacy education in West Bengal

27

8

Pharmacotherapy discussion groups in the Netherlands under the spotlight. G. Kocken

25/26

31

Essential drugs concept needs better implementation. K. Weerasuriya, P. Brudon

25/26

32

New Belgian committee promotes rational prescribing

25/26

33

Pakistan's largest Province focuses on drug sector reform

25/26

34

MSF Research Group on Essential Drugs: fighting for the underprivileged. J. Pinel Making injections safe 25/26 35

25/26

34

Calcutta's Community Development Medicinal Unit's leadership training on rational use of drugs

25/26

35

Stepping beyond with community-directed treatment

25/26

36

Rational use of drugs the Santa Fe way. D. Fontana

24

28

Ugandan doctors want antibiotic moratorium

24

28

International Conference on Improving Use of Medicines

23

6

Improving drug use in Africa: HAI's new initiative. L. Hayes

23

13

French monitor prescribing

23

13

Catching them young - the key to improving rational use M.V. Natu, M.M. Deodhar, S.K. Leekha

23

14

Moves to strengthen pharmacy curricula

23

14

Netherlands: inventory of RUD groups

23

14

Clinical guidelines in Scotland: a SIGN of the times J. Petrie

22

13

Zimbabwe targets prescribing of opinion leaders. B. Trap, C. Lessing

21

4

Effective drug management: Thai course spreads the message. P. Spivey

21

5

India: guidelines on rational use in medical curricula

21

5

Philippines: monitoring drug prices

21

5

Maldives: workshop boosts collaboration

21

6

Rational use of drugs in the Balkans: a WHO workshop in the Former Yugoslav Republic of Macedonia. L. Offerhaus

20

3

The NAPRALERT database: linking traditional and modern medicine. N. Farnsworth, C. Beecher, H. Fong

20

2

Research

Analysing drug advertisements in Russia

31

10

Canadian survey on direct-to-consumer advertising

31

10

Research updates

31

11

Namibia adopts WHO/INRUD indicators

30

17

Research updates

30

17

Burkina Faso: study shows value of qualitative monitoring

28/29

31

Science shopping in the Netherlands

28/29

31

Advantages of pre-packaged antimalarials

25/26

20

Survey highlights failings in public education in rational drug use

25/26

18

Improving quality of care in Hai Phong Province, Viet Nam. J. Chalker

25/26

15

French study asks why so many unnecessary drugs are given to children with diarrhoea

24

22

Investigating popular demand for injections in Indonesia and Uganda. A. Hardon, A. van Staa

23

15

Where Thai villagers get their drugs. L. Sringernyuang, T. Hongvivatana, P. Pradabmuk

21

28

Changing doctors' prescribing patterns: results of Mexican study

20

9

Thailand: a new approach to data collection

20

9

Resource Centre encourages UK pharmacists' research studies. P. Abel

20

9

Boost for UK research into prescribing

20

8

Unnecessary injections: new study adds to the evidence. A. Reeler

20

8

Supply

Reducing costs through regional

pooled procurement. F. Burnett

32

7

Global TB Drug Facility: improving access to TB drugs. I. Smith, J. Kumaresan, V.Arnold.

32

19

Demistifying antiretroviral therapy in resource-poor settings. T. Kasper, D. Coetzee, F. Louis, K.Hilderbrand.

32

20

Health reform and drug financing

25/26

2

How "topping-up" improved drug management at a small clinic in Ghana. D.S. Marfo

25/26

4

Good drugs at low cost: Thailand's provincial collective bargaining system for drug procurement. M.N. Songkhla, S. Wibulpolprasert, P. Prakongsai

25/26

5

Drug supply choices: what works best?

25/26

7

"Contracting-out" drug procurement and distribution: experience with a primary distributor system in South Africa. R.S. Summers, H. Möller, D. Meyer, R. Botha

25/26

10

Improving the supply, quality control and access to essential drugs in Guatemala. M.E. Lezana

25/26

12

Educating the donor. Improving drug donations from Western Europe. M. Raijmakers, A. Petersen

23

2

Drug donation guidelines: gathering momentum

23

4

Vaccine donations: maximising the benefits

23

5

Formal requirements for donations in Norway

23

5

Time for evaluation

23

5

New guidelines for drug donations

21

6

India: Drug management in the Govern- ment Sector - the Tamil Nadu Model. R. Poornalingam

21

10

PROMESS: a model supply centre for essential drugs in Haiti. G. Rino Meyers

21

11

Traditional medicine

Research focuses on traditional antimalarials

28/29

35

India: protecting its heritage of medicinal plants

28/29

35

Training

Course offers flexible approach to community-based health education

25/26

20

Personal formulary system helps university students. T.P.G.M. de Vries

25/26

21

Building the interface between communities and the health system. K. Pangu

24

23

Next! is definitely not enough for Zimbabweans - a new training package on effective communication. C. Lessing, H. Moore, A. Chidarikire

23

24

Drug advertisements: a critical lesson for Indonesian students. S. Suryawati, B. Santoso

23

23

Drug promotion: push, promote or educate? The JIPMER video. C.H. Shashindran, K.R. Sethuraman

20

24

From research to action: the Gunungkidul experience. Dr Sunartono, Drs Darminto

20

21

Pharmacotherapy counselling groups in the Netherlands, a bottom-up approach. F.M. Haaijer-Ruskamp

20

20

Tried, tested and ready for use - the new Guide to Good Prescribing

20

18

New distance learning package in rational prescribing. M. Lidell

20

17

World Health Organization

World Health Assembly 1999

27

20

World Health Assembly keynote address: Searching for a deeper understanding of development 1999. A. Sen

27

21

World Health Assembly 1996: Drug discussions at the 49th WHA

21

23

World trade

WHO hosts meeting in Bangkok on traditional medicine

30

20

Regional meetings explore TRIPS

30

21

Delhi Declaration on trade issues

28/29

35

Fears over new regional patent agreement

28/29

35

Patents from a public health perspective. C. Correa

28/29

36

Trade policy must protect consumer rights says International Federation

27

15

Compulsory licensing debate continues

27

16

Pakistan: lively debate on TRIPS and access to drugs

27

16

Plea for a human face for globalisation: the Human Development Report 1999

27

17

Talking TRIPS again in South-East Asia

27

17

WHO gets mandate to tackle trade impacts on health

27

18

Patenting pharmaceuticals: a new global order. C. Correa

22

20

Theme issues

Year

Improving prescribing skills

20

1995

Drug donations

21

1996

Improving drug use

23

1997

Networking for action

24

1997

Managing drug supply

25/26

1998

Antimicrobial resistance

28/29

2000

Access

30

2001

Drug promotion

31

2002

25th anniversary of the essential medicines concept

32

2003